Home / For Your Practice (page 3)

For Your Practice

FOR YOUR PRACTICE

The Future of Type 1 Screening: Will Genetics Replace Autoantibodies?

Pediatric genetic screening for type 1 diabetes showing a DNA helix, blood sample, and clinical risk assessment used for early detection of disease risk.

Population-based screening for type 1 diabetes is entering a new era. While autoantibody testing remains the gold standard for identifying individuals at high risk, researchers are increasingly investigating whether type 1 diabetes genetic screening could identify susceptible people even earlier. Advances in genomic science now make it possible to estimate …

Read More »

Your Patient Is Taking a Compounded GLP-1. Now What?

Physician discussing compounded GLP-1 medication safety with a patient during a clinical consultation, with injectable medication vials and a syringe on the desk.

As demand for GLP-1 receptor agonists continues to outpace supply, many patients have turned to compounded medications obtained through telehealth companies, medical spas, wellness clinics, and compounding pharmacies. While these products may improve access for some individuals, they also introduce important clinical, regulatory, and medicolegal challenges. Providers increasingly encounter patients …

Read More »

The Diabetes Warning Sign Hiding in Routine Liver Tests

Routine liver enzyme blood test alongside a glucose meter illustrating the connection between liver enzymes and diabetes risk.

Many people think of liver function tests as a way to detect liver disease. However, researchers are discovering that routine liver enzymes may also reveal important clues about future metabolic health. Understanding liver enzymes diabetes risk is becoming increasingly important because these commonly ordered blood tests may help identify people …

Read More »

The Postpartum Cliff: Why So Many Women With Gestational Diabetes Never Get Follow-Up Care

New mother holding her baby while reviewing postpartum diabetes follow-up reminders and glucose screening recommendations after gestational diabetes.

Postpartum screening after gestational diabetes is one of the most important yet overlooked steps in preventing future type 2 diabetes. Although blood glucose levels often return to normal after delivery, the long-term metabolic risk does not disappear. In fact, up to half of individuals diagnosed with gestational diabetes mellitus (GDM) …

Read More »

Could Your Smartwatch Detect Diabetes Before a Blood Test?

Person wearing a smartwatch displaying metabolic health data alongside a blood glucose meter, illustrating wearable diabetes screening technology.

For decades, diagnosing diabetes has depended on blood tests performed during routine medical visits. However, what if your smartwatch could recognize early warning signs before glucose levels become high enough for a formal diagnosis? Researchers are now exploring wearable technologies for diabetes screening that continuously analyze physiologic data collected throughout …

Read More »

A Positive Type 1 Diabetes Screen Isn’t Always Equal: Why IA-2 Changes the Risk Calculation

Clinical illustration showing IA-2 autoantibody testing, type 1 diabetes risk assessment, blood sample analysis, and patient monitoring strategies used in islet autoantibody screening risk stratification.

As population-based screening for type 1 diabetes (T1D) becomes more common, clinicians increasingly encounter positive islet autoantibody results in children and adults who have no symptoms. However, not all positive screening results carry the same clinical significance. A single positive autoantibody may indicate elevated risk, yet the specific antibody detected …

Read More »

What Your Patient’s Skin May Be Telling You About Their Diabetes Risk

Healthcare provider examining a patient with visible diabetes skin manifestations, including acanthosis nigricans, diabetic dermopathy, and other dermatologic signs associated with diabetes risk and insulin resistance.

The skin is often described as a window into overall health, and in patients with diabetes or prediabetes, it may provide some of the earliest visible signs of underlying metabolic dysfunction. While laboratory testing remains the cornerstone of diabetes diagnosis, clinicians who recognize key skin manifestations of diabetes can identify …

Read More »

Fasting With Diabetes: How Clinicians Can Reduce Hypoglycemia and DKA Risk

Blood glucose monitor, insulin supplies, healthy meal, and dates arranged for safe diabetes fasting management

Patients with diabetes are increasingly exploring fasting for religious, cultural, and metabolic health reasons. From Ramadan observance to intermittent fasting trends, many individuals choose to abstain from food and fluids for extended periods despite potential risks. For clinicians, this creates an important challenge. Simply advising patients not to fast often …

Read More »

Can Environmental Chemicals Increase Diabetes Risk? What Emerging Research Suggests

Blood glucose meter beside pollution, plastics, and environmental exposure imagery illustrating environmental diabetes risk and metabolic health concerns.

Growing evidence suggests that diabetes risk may involve more than genetics, diet, and physical inactivity alone. Researchers are now studying whether environmental chemicals could influence metabolic health in ways that contribute to insulin resistance and type 2 diabetes. While the science is still developing, interest in how environmental exposures may …

Read More »

Why Oral Health Is Becoming Part of Diabetes Management

Dental professional examining healthy gums beside a glucose monitor to illustrate the connection between oral health and diabetes management.

A bleeding gumline might seem like a minor dental issue, but researchers are increasingly finding that it can signal much more than a need to floss. Chronic inflammation inside the mouth may influence blood sugar control, cardiovascular health, and even long-term diabetes outcomes. As evidence continues to grow, healthcare providers …

Read More »